Douek D C, Vescio R A, Betts M R, Brenchley J M, Hill B J, Zhang L, Berenson J R, Collins R H, Koup R A
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas 75390, USA.
Lancet. 2000 May 27;355(9218):1875-81. doi: 10.1016/S0140-6736(00)02293-5.
The potential benefits of haematopoietic stem-cell transplantation are tempered by the depletion of T-cells accompanying this procedure. We used a new technique which quantifies the excisional DNA products of T-cell-receptor (TCR) gene rearrangement to measure thymic output directly in patients with multiple myeloma, and thus assessed the contribution of the thymus to immune recovery after transplantation.
We studied 40 patients, 34-66 years of age, who had been randomly assigned myeloablative chemotherapy and autologous peripheral-blood haematopoietic stem-cell transplantation with unmanipulated grafts or grafts enriched for CD34 stem cells. CD4 and CD8 T-cell counts were measured, thymic output was estimated serially until 2 years after transplantation, and percentages of naive T-cells were measured.
The production of substantial numbers of new naive T cells by the thymus could be detected by 100 days post-transplant; there was a significant inverse relation between age and recovery of new T cells. In the CD34-unselected group, numbers of TCR-rearrangement excision circles returned to baseline after 2 years, whereas in the CD34-selected group, numbers at 2 years were significantly higher than both baseline numbers (p=0.004), and 2-year numbers in the unselected group (p=0.046). Increased thymic output correlated with, and was predictive of, increased naive T-cell numbers and broader T-cell-receptor repertoires.
Our results provide evidence that the adult thymus contributes more substantially to immune reconstitution after haematopoietic stem-cell transplantation than was previously thought, and therefore could be a target for therapeutic intervention.
造血干细胞移植的潜在益处因该过程中伴随的T细胞耗竭而受到影响。我们采用了一种新技术,该技术可对T细胞受体(TCR)基因重排的切除性DNA产物进行定量,以直接测量多发性骨髓瘤患者的胸腺输出量,从而评估胸腺对移植后免疫恢复的贡献。
我们研究了40例年龄在34至66岁之间的患者,这些患者被随机分配接受清髓性化疗及自体外周血造血干细胞移植,移植的是未处理的移植物或富含CD34干细胞的移植物。测量CD4和CD8 T细胞计数,连续评估胸腺输出量直至移植后2年,并测量初始T细胞的百分比。
移植后100天即可检测到胸腺产生大量新的初始T细胞;年龄与新T细胞的恢复之间存在显著的负相关关系。在未选择CD34的组中,TCR重排切除环的数量在2年后恢复至基线水平,而在选择CD34的组中,2年时的数量显著高于基线水平(p = 0.004),也高于未选择组2年时的数量(p = 0.046)。胸腺输出量增加与初始T细胞数量增加及T细胞受体库更广泛相关,并可预测这一情况。
我们的结果提供了证据,表明成年胸腺对造血干细胞移植后的免疫重建贡献比之前认为的更大,因此可能成为治疗干预的靶点。